Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Postischemic IDN-6734 produces sustained improvement following myocardial ischemia/reperfusion

Nov. 20, 2002

Metalloporphyrin inhibits cardiomyocyte apoptosis by inducing heme oxygenase

Nov. 20, 2002

Orally active MAPK inhibitor reduces VSMC proliferation and neointimal formation

Nov. 20, 2002

AtheroGenics awarded CIHR grant for CART-2 atherosclerosis trial

Nov. 19, 2002

Potential antiarrhythmic agent that predominantly blocks I(Kur) currents in atrium

Nov. 19, 2002

Cardiac isoform-selective inhibitor of adenylyl cyclase presented in Chicago

Nov. 19, 2002

Kowa describes compounds with dual antiplatelet/vasodilating activity

Nov. 19, 2002

Aventis claims novel angiotensin(1-7) receptor agonists for angina pectoris and other disorders

Nov. 19, 2002

New data on the safety of drotrecogin alfa (activated) in severe sepsis

Nov. 19, 2002

Merck KGaA and Grupo Vita announce manufacturing and licensing agreement for Eneas

Nov. 18, 2002

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...